Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.

Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.

Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.

Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.

Provided is an active material used for a sodium ion battery or a lithium ion battery, the active material including: (COONa).sub.3-trioxotriangulene represented by the following Formula (1) or (COOLi).sub.3-trioxotriangulene represented by the following Formula (2). ##STR00001## In Formulae (1) and (2), a double line including a solid line and a broken line represents a single bond or a double bond.

Provided is an active material used for a sodium ion battery or a lithium ion battery, the active material including: (COONa).sub.3-trioxotriangulene represented by the following Formula (1) or (COOLi).sub.3-trioxotriangulene represented by the following Formula (2). ##STR00001## In Formulae (1) and (2), a double line including a solid line and a broken line represents a single bond or a double bond.

The invention provides a method for the preparation of regioisomerically pure intermediates which are useful for the preparation of carboxy-fluorescein-type compounds. Such compounds have broad applications within bio-conjugation and/or fluorescent imaging.

The invention provides a method for the preparation of regioisomerically pure intermediates which are useful for the preparation of carboxy-fluorescein-type compounds. Such compounds have broad applications within bio-conjugation and/or fluorescent imaging.

The invention provides a method for the preparation of regioisomerically pure intermediates which are useful for the preparation of carboxy-fluorescein-type compounds. Such compounds have broad applications within bio-conjugation and/or fluorescent imaging.

Described herein are compositions and methods for preventing and/or treating diseases involving aberrant angiogenesis employing one or more benzo[c]chromen-6-one derivatives.